Eight patients with acute nonlymphocytic leukemia (ANLL) and five patients with acute lymphocytic leukemia were treated with aclacinomycin A. It was given daily by one-hour infusion in doses ranging from 0.33 to 0.70 mg/kg for seven to 20 days without other antileukemic agents. Two patients with ANLL achieved complete remission and one with ANLL achieved partial remission. Its major toxic effects were myelosuppression and gastrointestinal symptoms.
|Number of pages||8|
|Journal||Japanese journal of clinical oncology|
|Publication status||Published - Jun 1 1980|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cancer Research